Approval · Notice of Compliance 19445 · 2017
DUODOPA: Notice of Compliance 19445
Issued June 20, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19445
- Date
- June 20, 2017
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUODOPA | Not yet assigned | — |
Medicinal ingredients
- LEVODOPA 2 G per 100ML
- CARBIDOPA MONOHYDRATE 0.5 G per 100ML